Remark Med (MARK) Reports Q2 Loss of $0.34/Share
Tweet
Share
E-mailGet Alerts MARK Hot Sheet
Join SI Premium – FREE
Remark Med (NASDAQ: MARK) reported Q2 EPS of ($0.34), versus ($0.19) reported last year.
For earnings history and earnings-related data on Remark Med (MARK) click here.
For earnings history and earnings-related data on Remark Med (MARK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Barclays Downgrades Travelers (TRV) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
